Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medigus Ltd receives FDA clearance for next generation MUSE system


Sunday, 23 Mar 2014 04:03am EDT 

Medigus Ltd:Says that United States Food and Drug Administration (FDA) has granted 510(k) clearance for next generation MUSE system, formerly known as the SRS system.MUSE is a device which enables an incisionless procedure by performing an anterior partial fundoplication with standard surgical staples in a less invasive way.Procedure currently targets patients with symptomatic chronic gastroesophageal reflux disease (GERD.MUSE system provides these patients, who are typically at higher risk of developing esophageal cancer, with potential long-term solution which aims to restore the esophageal anatomy with minimally invasive tool in order to reduce or eliminate their GERD symptoms. 

Company Quote

46.4
-1.5 -3.13%
22 Sep 2014